HUP0101584A2 - Benzofuroxán-származékok és alkalmazásuk angina pectoris kezelésére - Google Patents

Benzofuroxán-származékok és alkalmazásuk angina pectoris kezelésére

Info

Publication number
HUP0101584A2
HUP0101584A2 HU0101584A HUP0101584A HUP0101584A2 HU P0101584 A2 HUP0101584 A2 HU P0101584A2 HU 0101584 A HU0101584 A HU 0101584A HU P0101584 A HUP0101584 A HU P0101584A HU P0101584 A2 HUP0101584 A2 HU P0101584A2
Authority
HU
Hungary
Prior art keywords
alkyl group
angina pectoris
carbon atoms
hydrogen atom
treating angina
Prior art date
Application number
HU0101584A
Other languages
English (en)
Inventor
Alangudi Sankaranarayanan
Original Assignee
Torrent Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd. filed Critical Torrent Pharmaceuticals Ltd.
Publication of HUP0101584A2 publication Critical patent/HUP0101584A2/hu
Publication of HUP0101584A3 publication Critical patent/HUP0101584A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

A találmány a benzofuroxán-sorozatba tartozó, kardiovaszkulárisrendellenességek kezelésére szolgáló, új (I) általános képletűvegyületekre vonatkozik, mely képletben R jelentése -O-(CH2)n-X-R';ahol n=1-6; X jelentése -NHC(O)- vagy oxigénatom; R' jelentése 1-8szénatomos alkilcsoport, aromás, heteroaromás, heteroatomként 1 vagy 2nitrogén- vagy oxigénatomot tartalmazó szubsztituált vagyszubsztituálatlan heterociklusos gyűrű, ahol a szubsztituens 1-8szénatomos alkilcsoport; vagy R jelentése (a)-(e) képletű csoportokegyike, ahol R< hidrogénatom, nitro-, 1-8 szénatomos alkil- vagy -C(O)-R<' csoport, ahol R<' hidrogénatom, kisszénatomos alkil- vagyarilcsoport. A találmány tárgyát képezik ezeknek a vegyületeknek azelőállítási eljárásai, ezeket tartalmazó gyógyszerkészítmények ésalkalmazásuk NO-donorként és/vagy szívkoszorúér betegségekben. Ó
HU0101584A 1998-05-22 1999-05-17 Benzofuroxan derivatives and their use in treating angina pectoris HUP0101584A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN935CA1998 IN188837B (hu) 1998-05-22 1998-05-22
PCT/IB1999/000892 WO1999061430A1 (en) 1998-05-22 1999-05-17 Benzofuroxan derivatives and their use in treating angina pectoris

Publications (2)

Publication Number Publication Date
HUP0101584A2 true HUP0101584A2 (hu) 2001-11-28
HUP0101584A3 HUP0101584A3 (en) 2002-12-28

Family

ID=11085434

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0102057A HUP0102057A3 (en) 1998-05-22 1999-05-17 Use of benzofuroxan derivatives in treating angina pectoris
HU0101584A HUP0101584A3 (en) 1998-05-22 1999-05-17 Benzofuroxan derivatives and their use in treating angina pectoris

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU0102057A HUP0102057A3 (en) 1998-05-22 1999-05-17 Use of benzofuroxan derivatives in treating angina pectoris

Country Status (16)

Country Link
US (2) US6248895B1 (hu)
EP (2) EP1079829B1 (hu)
JP (2) JP3378239B2 (hu)
CN (2) CN1302205A (hu)
AT (2) ATE270279T1 (hu)
AU (2) AU3623299A (hu)
BR (2) BR9910637A (hu)
CA (2) CA2333001A1 (hu)
CZ (1) CZ20004072A3 (hu)
DE (2) DE69918431T2 (hu)
ES (1) ES2222029T3 (hu)
HU (2) HUP0102057A3 (hu)
IN (1) IN188837B (hu)
PT (1) PT1080081E (hu)
RU (2) RU2209065C2 (hu)
WO (2) WO1999061018A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
AU2002366756A1 (en) * 2001-12-20 2003-07-09 Alangudi Sankaranarayanan Use of benzofuroxan derivatives as antiplatelet agents
WO2003088961A1 (en) 2002-04-19 2003-10-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
EP1578413A2 (en) * 2002-11-29 2005-09-28 Yissum Research Development Company of The Hebrew University of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
US7093310B2 (en) * 2005-01-03 2006-08-22 Miranda Industries, Inc. Beddress
US8822509B2 (en) * 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
CN101270068B (zh) * 2008-04-23 2011-05-18 常州亚邦齐晖医药化工有限公司 一种2-硝基-4-丙硫基苯胺的制备方法
WO2010000019A1 (en) * 2008-07-02 2010-01-07 The University Of Queensland Pain-relieving compositions of furoxan no donors and uses thereof
RU2515413C2 (ru) * 2012-07-05 2014-05-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Производные 1,2,5-оксадиазолов, обладающие анти-вич активностью, фармацевтическая композиция, способ ингибирования интегразы вич-1
US8945338B2 (en) 2013-03-15 2015-02-03 Henkel US IP LLC Anaerobic curable compositions
CN104592145B (zh) * 2015-01-15 2017-05-17 山东大学 一种苯并氧化呋咱组蛋白去乙酰化酶抑制剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567728A (en) * 1968-07-05 1971-03-02 Pfizer Process for the preparation of phenazine di-n-oxides and related compounds
US4014893A (en) * 1973-05-11 1977-03-29 Imperial Chemical Industries Limited 3,4-Cycloalkano furoxans
US4185018A (en) * 1978-08-21 1980-01-22 Ciba-Geigy Corporation Process for producing benzofurazan-1-oxides
US4544400A (en) * 1982-02-22 1985-10-01 Zoecon Corporation Compositions
JPS6072874A (ja) * 1983-09-28 1985-04-24 Kazuhiro Imai ２，１，３−ベンゾオキサジアゾ−ルの新規誘導体
JPS6383078A (ja) * 1986-09-25 1988-04-13 Honsyu Kagaku Kogyo Kk ベンゾフラザン−１−オキシドの製造方法
US5272164A (en) 1988-12-27 1993-12-21 Kirin Beer Kabushiki Kaisha Carboximidamide derivatives
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
DE4218977A1 (de) * 1992-06-10 1993-12-16 Cassella Ag Annellierte 1,2,5-Oxadiazol-2-oxide
DE4220264A1 (de) 1992-06-20 1993-12-23 Cassella Ag Phenyl-1,2,5-oxadiazol-carbonamid-2-oxide
US6110935A (en) * 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses

Also Published As

Publication number Publication date
EP1080081B1 (en) 2004-06-30
HUP0101584A3 (en) 2002-12-28
AU3623299A (en) 1999-12-13
BR9910637A (pt) 2001-02-06
CZ20004072A3 (cs) 2001-08-15
CN1302205A (zh) 2001-07-04
WO1999061018A1 (en) 1999-12-02
WO1999061430A1 (en) 1999-12-02
IN188837B (hu) 2002-11-09
PT1080081E (pt) 2004-10-29
ATE245419T1 (de) 2003-08-15
BR9910628A (pt) 2001-01-30
JP2002516275A (ja) 2002-06-04
EP1080081A1 (en) 2001-03-07
CN1301258A (zh) 2001-06-27
ES2222029T3 (es) 2005-01-16
JP2002516317A (ja) 2002-06-04
DE69918431D1 (de) 2004-08-05
EP1079829A1 (en) 2001-03-07
EP1079829B1 (en) 2003-07-23
RU2222532C2 (ru) 2004-01-27
HUP0102057A3 (en) 2002-12-28
RU2209065C2 (ru) 2003-07-27
US6232331B1 (en) 2001-05-15
US6248895B1 (en) 2001-06-19
HUP0102057A2 (hu) 2001-11-28
ATE270279T1 (de) 2004-07-15
CA2333001A1 (en) 1999-12-02
DE69909782D1 (de) 2003-08-28
AU3623399A (en) 1999-12-13
JP3378239B2 (ja) 2003-02-17
CA2332950A1 (en) 1999-12-02
DE69918431T2 (de) 2005-07-14

Similar Documents

Publication Publication Date Title
RU94046169A (ru) Гетероциклические соединения, способ их получения, способ разделения оптических изомеров, фармкомпозиция, способ лечения
PT863875E (pt) Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal
FI935529A0 (fi) Aminometylensubstituerade icke-aromatiska heterocykliska foereningar
ATE124695T1 (de) Kondensierte heterocyclische verbindungen, ihre herstellung und verwendung.
RU95108387A (ru) Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина
FI941022A0 (fi) Spirosykliset piperidiinijohdannaiset
FI931370A (fi) Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring
HUP0101584A2 (hu) Benzofuroxán-származékok és alkalmazásuk angina pectoris kezelésére
DE69429364T2 (de) Verwendung von steroidderivaten als arzneimittel
NO982913L (no) Kinolin- og kinazolinforbindelser nyttige i terapi
TR199800655T2 (xx) Yeni heterosiklik t�revler ve bunlar�n farmas�tik kullan�mlar�.
ATE202702T1 (de) Verwendung von oestrogenagonisten und - antagonisten zur herstellung eines medikaments zur behandlung von atherosklerose, unabhängig von lipidsenkung
DE60224664D1 (de) Substituierte tetrhydroisochinolin-derivate zur behandlung von entzündlichen erkrankungen
ATE251624T1 (de) Granulatimide-derivate zur behandlung von krebs
DE69202120D1 (de) Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie.
DE3788612T2 (de) Chinoxalin-Verbindungen und deren Herstellung und Verwendung.
EA199700288A1 (ru) Таксоиды, способы их получения и фармацевтическая композиция на их основе
EA200000389A3 (ru) Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции
HUP9901247A2 (hu) Naftimidazol-, naftoxazol- és naftotiazol-dion-származékok alkalmazása érrendszeri elváltozások okozta betegségek kezelésére szolgáló gyógyszerkészítmények előállítására, valamint új származékok
MXPA05004845A (es) N-oxidos y derivados de melfalan para el tratamiento de estados de enfermedad asociados a un factor inducible por hipoxia.
DE60000410T2 (de) Heterocyclische derivate als inhibitoren von faktor xa
HUP0003861A2 (hu) Kinolin-4-il-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
ATE229953T1 (de) Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
ITMI920082A1 (it) Derivati solforati di acidi biliari
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees